Aldosterone resistance in kidney transplantation is in part induced by a down-regulation of mineralocorticoid receptor expression

Clinical Transplantation

Volumn 18, Issue 2, 2004, Pages 186-192

  Heering, P J ^a   Kurschat, C ^b   Vo, D T ^a   Klein Vehne, N ^b   Fehsel, K ^b   Ivens, K ^b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Aldosterone receptors; Cyclosporin A; Kidney transplantation

Indexed keywords

ALDOSTERONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BICARBONATE; CREATININE; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLUDROCORTISONE; MINERALOCORTICOID; MINERALOCORTICOID RECEPTOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; POTASSIUM; PREDNISOLONE; RNA; THYMOCYTE ANTIBODY;

ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; BICARBONATE BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; DRUG BLOOD LEVEL; ELECTROLYTE DISTURBANCE; HORMONE RESISTANCE; HUMAN; HYPERKALEMIA; KIDNEY DYSFUNCTION; KIDNEY TRANSPLANTATION; LEUKOCYTE; METABOLIC ACIDOSIS; PATHOPHYSIOLOGY; POTASSIUM METABOLISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; RECIPIENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WATER METABOLISM;

ACIDOSIS; ADULT; ALDOSTERONE; BODY WATER; CALCINEURIN; CYCLOSPORINE; DOWN-REGULATION; FLUDROCORTISONE; HOMEOSTASIS; HUMANS; HYPERKALEMIA; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LEUKOCYTES; MIDDLE AGED; POTASSIUM; RECEPTORS, MINERALOCORTICOID; RENIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; WATER-ELECTROLYTE IMBALANCE;

EID: 1642483691     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1399-0012.2003.00154.x     Document Type: Article

References (22)

1. Bonvalet JP. Regulation of sodium transport by steroid hormones. Kidney Int Suppl 1998: 65: OS49.
2. Lombès M, Binart N, Delahaye F, Baulieu EE, Rafestin-oblin ME. Differential intracellular localization of human mineralocorticosteroid receptor on binding of agonists and antagonists. Biochem J 1994: 302: 191.
3. Lombès M, Binart N, Oblin M-E, Joulin V, Baulieu EE. Characterization of the interaction of the human mineralocorticosteroid receptor with hormone responsive elements. Biochem J 1993: 292: 577.
4. Adu D, Turney J, Michael J, McMaster P. Hyperkalemia in cyclosporine treated renal allograft recipients. Lancet 1983: 2: 370.
5. Fleming DR, Ouseph R, Herrington J. Hyperkalemia associated with cyclosporine (CsA) use in bone marrow transplantation. Bone Marrow Transplant 1997: 19: 289.
6. Heering P, Ivens K, Aker S, Grabensee B. Distal tubular acidosis induced by FK506. Clin Transplant 1998: 12: 465.
7. Heering P, Grabensee B. Influence of cyclosporin A on renal tubular function after kidney transplantation. Nephron 1991: 59: 66.
8. Katari SR, Magnone M, Shapiro R et al. Clinical features of acute reversible tacrolimus (FK506) nephrotoxicity in kidney transplant recipients. Clin Transplant 1997: 11: 237.
9. Laine J, Holmberg C. Renal and adrenal mechanisms in cyclosporine-induced hyperkalaemia after renal transplantation. Eur J Clin Invest 1995: 25: 670.
10. Tumlin JA, Sands JM. Nephron segment-specific inhibition of Na+/K(+)-ATPase activity by cyclosporin A. Kidney Int 1993: 43: 246.
11. McCauley J, Fung JJ, Todo SA, Deballi P, Starzl TE. Changes in renal function after liver transplantation under FK506. Transplant Proc 1991: 23: 3143.
12. Armanini D, Spinella P, Simoncini M, et al. Regulation of corticosteroid receptors in patients with anorexia nervosa and cushing's syndrome. J Endocrinol 1998: 158: 435.
13. Fuse H, Kitagawa H, Kato S. Characterization of transactivational property and coactivator mediation of rat mineralocorticoid receptor activation function-1 (AF- 1). Mol Endocrinol 2000: 14: 889.
14. Govindan MV, Warriar N. Reconstitution of the N-terminal transcription activation function of human mineralocorticoid receptor in a defective human glucocorticoid receptor. J Biol Chem 1998: 273: 24439.
15. Czar MJ, Galigniana MD, Silverstein AM, Pratt WB. Geldanamycin, a heat shock protein 90-binding benzoquinone ansamycin, inhibits steroid-dependent translocation of the glucocorticoid receptor from the cytoplasm to the nucleus. Biochemistry 1997: 36: 7776.
16. Jette L, Beaulieu E, Leclerc JM, Beliveau R. Cyclosporin A treatment induces overexpression of P-glycoprotein in the kidney and other tissues. Am J Physiol 1996; 270: F756.
17. Masuda S, Uemoto S, Hashida T, Inomata Y, Tanaka K, Inui K. Effect of intestinal P-glycoprotein on daily tacrolimus trough level in a living-donor small bowel recipient. Clin Pharmacol Ther 2000: 68: 98.
18. Milad M, Sullivan W, Diehl E et al. Interaction of the progesterone receptor with binding proteins for FK506 and cyclosporin A. Mol Endocrinol 1995: 9: 838.
19. Szapary D, Xu M, Simons SS. Induction properties of a transiently transfected glucocorticoid-responsive gene vary with glucocorticoid receptor concentration. J Biol Chem 1996: 271: 30576.
20. Smith CL, Wolford RG, O'Neill TB, Hager GL. Characterization of transiently and constitutively expressed progesterone receptors: evidence for two functional states. Mol Endocrinol 2000: 14: 956.
21. Deppe C, Heering P, Viengchareun S, Grabensee B, Farman N, Lombes M. Cyclosporine A and FK506 inhibit transcriptional activity of the human mineralocorticoid receptor: A cell based model to investigate partial aldosterone resistance in kidney transplantation. Endocrinology 2002: 143: 1932.
22. Zennaro M-C, Farman N, Bonvalet J-P, Lombès M. Tissue-specific expression of alpha and beta mRNA isoforms of the human mineralocorticoid receptor in normal and pathological states. J Clin Endocrinol Metab 1997: 82: 1345.